XML 12 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Series X1 Non-voting Convertible Preferred Stock [Member]
Series X Non-Voting Convertible Preferred Stock [Member]
Beginning Balance at Dec. 31, 2023 $ 7,208 $ 24 $ 326,586   $ (319,402)    
Beginning Balance, Shares at Dec. 31, 2023   24,213,130       110,086 4,422
Issuance of common stock in connection with exercise of pre-funded warrants, Shares   600,000          
Issuance of common stock in connection with exercise of pre-funded warrants, Value 1 $ 1          
Stock-based compensation 1,694   1,694        
Net loss (23,631)       (23,631)    
Ending Balance at Mar. 31, 2024 (14,728) $ 25 328,280   (343,033)    
Ending Balance, Shares at Mar. 31, 2024   24,813,130       110,086 4,422
Beginning Balance at Dec. 31, 2024 118,140 $ 60 473,640 $ 26 (355,586)    
Beginning Balance, Shares at Dec. 31, 2024   59,789,275       110,086 4,422
Issuance of common stock in connection with vesting of restricted stock units   42,500          
Stock option exercise, Shares   50,000          
Stock option exercise, Value 115   115        
Stock-based compensation 2,864   2,864        
Other comprehensive loss (44)     (44)      
Net loss (6,495)       (6,495)    
Ending Balance at Mar. 31, 2025 $ 114,580 $ 60 $ 476,619 $ (18) $ (362,081)    
Ending Balance, Shares at Mar. 31, 2025   59,881,775       110,086 4,422